Announcements Trials
Browse Landscape

Phase

Phase 1/2 14Phase 2 10Phase 1 9Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 9Gastrointestinal 3NET 2Thoracic 1Dermatologic 1CNS 1

Conditions

Lung Neoplasms 1332Carcinoma, Non-Small-Cell Lung 631Breast Neoplasms 162Neoplasms 99Small Cell Lung Carcinoma 93Prostatic Neoplasms 86Colorectal Neoplasms 79Motor Activity 63Colonic Neoplasms 62Head and Neck Neoplasms 60Esophageal Neoplasms 49Disease 46Pancreatic Neoplasms 45Melanoma 41Stomach Neoplasms 39Urinary Bladder Neoplasms 37Ovarian Neoplasms 37Pleural Effusion, Malignant 36Neoplasm Metastasis 35Brain Neoplasms 29Gastrointestinal Neoplasms 28Pulmonary Disease, Chronic Obstructive 27Anxiety Disorders 27Lung Diseases 26Liver Neoplasms 26Carcinoma, Renal Cell 26Adenocarcinoma of Lung 26Thoracic Neoplasms 25Mesothelioma 24Lymphoma 24

Interventions

Radiotherapy 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Neuroendocrine × Thoracic × Clear all
NCT02357992 2022-10-14

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

M.D. Anderson Cancer Center

Phase NA Completed
122 enrolled 10 charts
EndocrineThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡